Literature DB >> 10735876

A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis.

Y Masaoka1, Y Ueno, Y Morita, T Kuroda, T Mizushima, T Tsuchiya.   

Abstract

Genes (ebrAB) responsible for ethidium resistance were cloned from chromosomal DNA of Bacillus subtilis ATCC 9372. The recombinant plasmid produced elevated resistance against ethidium bromide, acriflavine, pyronine Y, and safranin O not only in Escherichia coli but also in B. subtilis. It also caused an elevated energy-dependent efflux of ethidium in E. coli. EbrA and EbrB showed high sequence similarity with members of the small multidrug resistance (SMR) family of multidrug efflux pumps. Neither ebrA nor ebrB was sufficient for resistance, but introduction of the two genes carried on different plasmids conferred drug resistance. Thus, both EbrA and EbrB appear to be necessary for activity of the multidrug efflux pump. In known members of the SMR family, only one gene produces drug efflux. Thus, EbrAB is a novel SMR family multidrug efflux pump with two components.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735876      PMCID: PMC111282          DOI: 10.1128/JB.182.8.2307-2310.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  Transduction of linked genetic characters of the host by bacteriophage P1.

Authors:  E S LENNOX
Journal:  Virology       Date:  1955-07       Impact factor: 3.616

2.  Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.

Authors:  A A Neyfakh; V E Bidnenko; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Bacillus subtilis as a host for molecular cloning.

Authors:  P S Lovett; K M Keggins
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot.

Authors:  D Eisenberg; E Schwarz; M Komaromy; R Wall
Journal:  J Mol Biol       Date:  1984-10-15       Impact factor: 5.469

5.  A staphylococcal multidrug resistance gene product is a member of a new protein family.

Authors:  L Grinius; G Dreguniene; E B Goldberg; C H Liao; S J Projan
Journal:  Plasmid       Date:  1992-03       Impact factor: 3.466

6.  Replacement of a phosphoenolpyruvate-dependent phosphotransferase by a nicotinamide adenine dinucleotide-linked dehydrogenase for the utilization of mannitol.

Authors:  S Tanaka; S A Lerner; E C Lin
Journal:  J Bacteriol       Date:  1967-02       Impact factor: 3.490

7.  Nucleotide sequence and comparative analysis of the frd operon encoding the fumarate reductase of Proteus vulgaris. Extensive sequence divergence of the membrane anchors and absence of an frd-linked ampC cephalosporinase gene.

Authors:  S T Cole
Journal:  Eur J Biochem       Date:  1987-09-15

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus.

Authors:  M Sasatsu; Y Shibata; N Noguchi; M Kono
Journal:  FEMS Microbiol Lett       Date:  1992-06-01       Impact factor: 2.742

View more
  38 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Effects of nonpolar mutations in each of the seven Bacillus subtilis mrp genes suggest complex interactions among the gene products in support of Na(+) and alkali but not cholate resistance.

Authors:  M Ito; A A Guffanti; W Wang; T A Krulwich
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

3.  Global analysis of genes regulated by EvgA of the two-component regulatory system in Escherichia coli.

Authors:  Kunihiko Nishino; Yoshihiko Inazumi; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

Review 4.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli.

Authors:  Che Ma; Geoffrey Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

6.  Topologically random insertion of EmrE supports a pathway for evolution of inverted repeats in ion-coupled transporters.

Authors:  Iris Nasie; Sonia Steiner-Mordoch; Ayala Gold; Shimon Schuldiner
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

7.  Genome-wide analyses of Escherichia coli gene expression responsive to the BaeSR two-component regulatory system.

Authors:  Kunihiko Nishino; Takeshi Honda; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

8.  Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.

Authors:  Estelle Marrer; Karen Schad; Andreas T Satoh; Malcolm G P Page; Maggie M Johnson; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

9.  X-ray structure of EmrE supports dual topology model.

Authors:  Yen-Ju Chen; Owen Pornillos; Samantha Lieu; Che Ma; Andy P Chen; Geoffrey Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

10.  Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.

Authors:  Vijaya Bharathi Srinivasan; Govindan Rajamohan; Wondwossen A Gebreyes
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.